BridgeBio Pharma Inc filed a certificate designating 933,900 shares of Series A cumulative preferred stock. This corporate equity designation is a standard capitalization update with no immediate impact on operations.
BridgeBio Pharma Inc filed a certificate designating 933,900 shares of Series A cumulative preferred stock. This corporate equity designation is a standard capitalization update with no immediate impact on operations.